Advertisement
Advertisement
PTGX
Protagonist Therapeutics, Inc
97.25
USDSponsored
-0.13
-0.14%
Jun 08, 14:26 UTC -4
Open
PTGX Earnings Reports
Positive Surprise Ratio
PTGX beat 24 of 40 last estimates.
60%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$217.64M
/$1.97
Implied change from Q1 26 (Revenue/ EPS)
+286.10%
/+3840.00%
Implied change from Q2 25 (Revenue/ EPS)
+3824.18%
/-458.18%
Protagonist Therapeutics, Inc earnings per share and revenue
On May 05, 2026, PTGX reported earnings of 0.05 USD per share (EPS) for Q1 26, beating the estimate of -0.54 USD, resulting in a 109.20% surprise. Revenue reached 56.37 million, compared to an expected 16.60 million, with a 239.59% difference. The market reacted with a -0.31% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of 1.97 USD, with revenue projected to reach 217.64 million USD, implying an increase of 3840.00% EPS, and increase of 286.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
What were Protagonist Therapeutics, Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Protagonist Therapeutics, Inc reported EPS of $0.05, beating estimates by 109.2%, and revenue of $56.37M, 239.59% above expectations.
How did the market react to Protagonist Therapeutics, Inc's Q1 2026 earnings?
The stock price moved down -0.31%, changed from $99.52 before the earnings release to $99.21 the day after.
When is Protagonist Therapeutics, Inc expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Protagonist Therapeutics, Inc's next earnings report?
Based on 12
analysts, Protagonist Therapeutics, Inc is expected to report EPS of $1.97 and revenue of $217.64M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement